BioSpace News Archive

Halberd Corporation successfully eradicated 85% of Tumor Necrosis Factor-alpha from synthetic cerebral spinal fluid in preliminary testing.

FogPharma today announced the appointments of Lihua Yu, Ph.D., as chief data officer and Keith Orford, M.D., Ph.D., as chief medical officer and executive vice president of clinical and translational science.

IMV Inc. today announced that Pierre Labbé, the Company’s Chief Financial Officer, will retire on March 31, 2022.

Pear Therapeutics, Inc. today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its reSET-A™ PDT product candidate designed for the treatment of alcohol use disorder (AUD).

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that a new post hoc analysis of the UPLIZNA N-MOmentum Phase 2/3 pivotal trial has been published in Multiple Sclerosis and Related Disorders showing that prior rituximab exposure did not impact the efficacy of UPLIZNA, and that UPLIZNA demonstrated comparable efficacy to trial participants without prior exposure to rituximab.

Paragon 28, Inc. announced today that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will virtually present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

Arcturus Therapeutics Holdings Inc. today announced that members of the Company’s management team will be participating in the Piper Sandler’s 33rd Annual Virtual Healthcare Conference and investor meetings November 30 and December 2, 2021.

Regencell Bioscience Holdings Limited announced that Yat-Gai Au, the Company’s Chairman & CEO, made Ordinary Share purchases of Regencell (“Ordinary Shares”) totaling $1,125,807.

Ascentage Pharma today announced that the European Commission (EC) has granted the company’s novel drug candidate, olverembatinib (HQP1351), an Orphan Designation for the treatment of chronic myeloid leukemia (CML).

Biocept, Inc. now offers a single test that can detect and distinguish between SARS-CoV-2 and influenza, helping patients and caregivers determine appropriate treatment decisions.